Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from BONESUPPORT HOLDING AB ( (SE:BONEX) ) is now available.
BONESUPPORT HOLDING AB announced a correction in its Q3 2025 interim report, specifically in the section detailing non-IFRS alternative performance measures. The error pertained to the US net sales at constant exchange rates, which should have been reported as SEK 269.6 million with a 40% growth rate. This correction does not affect the main financial statements, ensuring the integrity of the overall financial report.
The most recent analyst rating on (SE:BONEX) stock is a Hold with a SEK270.00 price target. To see the full list of analyst forecasts on BONESUPPORT HOLDING AB stock, see the SE:BONEX Stock Forecast page.
More about BONESUPPORT HOLDING AB
BONESUPPORT HOLDING AB is a prominent company in the orthobiologics industry, specializing in innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and can elute drugs. The company is based in Lund, Sweden, and focuses on demonstrating the clinical and health economic benefits of its products through various clinical studies.
Average Trading Volume: 182,218
Technical Sentiment Signal: Sell
Current Market Cap: SEK14.42B
For a thorough assessment of BONEX stock, go to TipRanks’ Stock Analysis page.